SEC Form 4 · accession 0001179110-16-027919
MADRIGAL PHARMACEUTICALS, INC. · MDGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fred B Craves
Director · 10% Owner
Period of report
Jul 22, 2016
Accepted (ET)
Jul 26, 2016 · 5:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157601
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 22, 2016 | A | 296,067 | $0.00 | A | 296,067 | D | |
| Common StockF1,F2 | Jul 22, 2016 | A | 5,538,474 | $0.00 | A | 5,538,474 | I | Bay City Capital Fund IV, L.P. ("Fund IV") |
| Common StockF1,F3 | Jul 22, 2016 | A | 119,380 | $0.00 | A | 119,380 | I | Bay City Capital Fund IV Co-Investment Fund, L.P. ("Co-Investment") |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares issued relate to the exchange of shares of Madrigal Pharmaceuticals, Inc. (as a private company) for shares of Synta Pharmaceuticals Corp. per Synta's agreement to acquire Madrigal, dated April 13, 2016. After the completion of the Merger, Synta Pharmaceuticals Corp. changed its name to Madrigal Pharmaceuticals, Inc.
- F2Dr. Craves disclaims beneficial ownership of these securities owned by Fund IV, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in Bay City Capital LLC, which is the manager of Fund IV's general partner, Bay City Capital Management IV LLC.
- F3Dr. Craves disclaims beneficial ownership of these securities owned by Co-Investment, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in Bay City Capital LLC, which is the manager of Co-Investment's general partner, Bay City Capital Management IV LLC.